MedPath

Solace Stress Urinary inContinence Control Efficacy and Safety Study

Not Applicable
Completed
Conditions
Stress Urinary Incontinence
Interventions
Device: Solace Bladder Control (Vesair) Balloon
Device: Solace Sham Treatment
Registration Number
NCT02210273
Lead Sponsor
Solace Therapeutics, Inc.
Brief Summary

The SUCCESS Trial is designed to determine whether the Solace Bladder Control System is safe and effective for the treatment of Stress Urinary Incontinence (SUI) in adult females.

Detailed Description

Subject will undergo treatment with the Solace Bladder Control System or a sham procedure, with the results being compared at 3 months.

All patients undergoing sham treatment are treated at 3 months.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
221
Inclusion Criteria
  • Female 18 years of age or older with stress urinary incontinence (SUI)
  • Experienced SUI for at least 12 months and attempted and failed prior noninvasive treatment
  • Willing to undergo cystoscopic procedures required and 36 month follow-up
  • On stable medication for a minimum of 3 months
  • Free of local genital skin infection
  • Positive Pad Weight Test
  • Free of impassable urethral strictures, trauma or necrosis
Exclusion Criteria
  • Pregnant or planning to become pregnant during the study period
  • Non-ambulatory or bedridden or physically unable to complete test exercises
  • Morbidly obese (defined as BMI ≥ 40 kg/m2)
  • Incontinence of neurogenic etiology
  • Urge predominant Mixed Incontinence
  • Bladder infection (including bladder inflammation or edema) or Urinary Tract Infection (UTI) within 3 months
  • History of recurrent urinary tract infections
  • Prior surgical procedure for incontinence within the past 6 months
  • Is taking medications for urinary incontinence other than anticholinergics
  • History of recurrent (>1) or recent (within 5 years) kidney stone(s)
  • Has a prosthetic heart valve
  • Unable to tolerate any form of antibiotic
  • Taking anticoagulation therapy, other than aspirin
  • Has urinary incontinence due to Intrinsic Sphincter Deficiency (ISD)

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Solace Sham TreatmentSolace Bladder Control (Vesair) BalloonSubjects undergoing sham treatment on day 0, and treatment with the Solace Bladder Control (Vesair) Balloon at 3 months
TreatmentSolace Bladder Control (Vesair) BalloonSubjects undergoing treatment with the Solace Bladder Control (Vesair) Balloon on day 0
Solace Sham TreatmentSolace Sham TreatmentSubjects undergoing sham treatment on day 0, and treatment with the Solace Bladder Control (Vesair) Balloon at 3 months
Primary Outcome Measures
NameTimeMethod
Improvement in quality of life as assessed by pad weight tests assessments and questionnaires3 Months

Comparison of increases in pad weight test and patient reported outcomes on questionnaires

Secondary Outcome Measures
NameTimeMethod
Incidence of treatment-related adverse events3 Months

Site-reported adverse events designated as related to the treatment

Severity of treatment-related adverse events3 Months

Site-reported adverse events designated as related to the treatment.

Trial Locations

Locations (18)

Valley Urogynecology Associates

🇺🇸

Phoenix, Arizona, United States

Sanford Female Pelvic Medicine and Reconstructive Surgery Clinic

🇺🇸

Sioux Falls, South Dakota, United States

Urological Associates of Southern Arizona

🇺🇸

Tucson, Arizona, United States

Urology Associates of Norwalk

🇺🇸

Norwalk, Connecticut, United States

Regional Urology

🇺🇸

Shreveport, Louisiana, United States

Women's Health Institute of Illinois

🇺🇸

Oak Lawn, Illinois, United States

Genitourinary Surgical Consultants

🇺🇸

Denver, Colorado, United States

WomanCare

🇺🇸

Arlington Heights, Illinois, United States

North Shore LIJ

🇺🇸

Great Neck, New York, United States

Female Pelvic Medicine and Urogynecology Institute of Michigan

🇺🇸

Grand Rapids, Michigan, United States

Chesapeake Urology

🇺🇸

Owings Mills, Maryland, United States

Premier Medical Group

🇺🇸

Poughkeepsie, New York, United States

Women and Infants Hospital

🇺🇸

Providence, Rhode Island, United States

MUSC Urology

🇺🇸

Charleston, South Carolina, United States

Virginia Women's Center

🇺🇸

Richmond, Virginia, United States

Integrity Medical Research

🇺🇸

Mountlake Terrace, Washington, United States

Urology of Virginia

🇺🇸

Virginia Beach, Virginia, United States

Lyndhurst Clinical Research

🇺🇸

Winston-Salem, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath